Companies Developing More Uses For Iontophoresis

The medical use of electricity dates back at least to the ancient Greeks, who used shocks from electric fish to treat gout. Modern medical researchers are more cautious about applying electrical energy to patients' bodies. Nevertheless, one electrically based technology, called iontophoresis, is growing in popularity, particularly among anesthesiologists and physical therapists. Increasing interest in the technique, which uses electric current to deliver drugs through the skin, has given rise t

Written byPeter Gwynne
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

The medical use of electricity dates back at least to the ancient Greeks, who used shocks from electric fish to treat gout. Modern medical researchers are more cautious about applying electrical energy to patients' bodies. Nevertheless, one electrically based technology, called iontophoresis, is growing in popularity, particularly among anesthesiologists and physical therapists. Increasing interest in the technique, which uses electric current to deliver drugs through the skin, has given rise to several companies that offer iontophoresis equipment. Yet some observers express concern that the number of applications may be increasing faster than clinical trials to test their efficacy and safety.

Iontophoresis resembles drug patch technology in that it is designed to force substances such as medications and anesthetics through the skin and into the body. It does so by applying a mild electric current to an ionic solution of the substance to be delivered. The technique relies on electrical repulsion: ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies